Agios Pharmaceuticals (MEX:AGIO) Accounts Payable : MXN337.6 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Agios Pharmaceuticals Accounts Payable?

Agios Pharmaceuticals's Accounts Payable for the quarter that ended in Sep. 2024 was MXN337.6 Mil.

Agios Pharmaceuticals's quarterly Accounts Payable declined from Mar. 2024 (MXN185.1 Mil) to Jun. 2024 (MXN183.8 Mil) but then increased from Jun. 2024 (MXN183.8 Mil) to Sep. 2024 (MXN337.6 Mil).

Agios Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (MXN342.6 Mil) to Dec. 2022 (MXN362.9 Mil) but then declined from Dec. 2022 (MXN362.9 Mil) to Dec. 2023 (MXN166.0 Mil).

Agios Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Agios Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals Accounts Payable Chart

Agios Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

412.96

352.57

342.58

362.94

166.01

Agios Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															231.17	166.01	185.13	183.84	337.55

Agios Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Agios Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Agios Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Agios Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (MEX:AGIO) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

AGIO:USA 0HB0:UK 8AP:Germany

Address

88 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.agios.com

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.